RenovoRx Appoints James Ahlers as Chief Financial Officer and Expands Finance Team with Addition of Ronald B. Kocak, CPA as Vice President and Controller
RenovoRx, Inc. (Nasdaq: RNXT) , a biopharmaceutical company and innovator in targeted cancer therapy, today is announcing the appointment of James Ahlers as Chief Financial Officer (CFO), effective July 15,…